Paper40709686
Developing Biomaterial-Based mRNA Delivery System for Lung Disease Treatment.
Gu Q and 7 others. Adv Sci (Weinh), 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Developing Biomaterial-Based mRNA Delivery System for Lung Disease Treatment. Papers, record 40709686. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40709686
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biocompatible Materials | Major topic |
| RNA, Messenger | Major topic |
| Lung Diseases | Major topic |
| Drug Delivery Systems | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 822770014 | National Natural Scientific Funds | PubMed | ||
| 81991523 | National Natural Scientific Funds | PubMed | ||
| 2018YFC1705900 | National Key Research and Development Program Project | PubMed | ||
| 2024SZRYBH180001 | Natural Science Foundation of Hangzhou | PubMed |
Source PubMed
References194
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31690379 | Asthma in adults: Principles of treatment. | Allergy Asthma Proc | 2019 | https://conductscience.org/library/papers/31690379 | PubMed |
| 2 | 23743667 | Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. | Lab Chip | 2013 | https://conductscience.org/library/papers/23743667 | PubMed |
| 3 | 38040120 | Long-acting inhaled medicines: Present and future. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38040120 | PubMed |
| 4 | 34504954 | Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer. | Biochem Biophys Rep | 2021 | https://conductscience.org/library/papers/34504954 | PubMed |
| 5 | 28150211 | Gene Silencing Using Multifunctionalized Gold Nanoparticles for Cancer Therapy. | Methods Mol Biol | 2017 | https://conductscience.org/library/papers/28150211 | PubMed |
| 6 | 28202367 | Exosomes: Therapy delivery tools and biomarkers of diseases. | Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28202367 | PubMed |
| 7 | 38865465 | Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice. | Sci Adv | 2024 | https://conductscience.org/library/papers/38865465 | PubMed |
| 8 | 23111789 | Microfluidic filtration system to isolate extracellular vesicles from blood. | Lab Chip | 2012 | https://conductscience.org/library/papers/23111789 | PubMed |
| 9 | 35446546 | Surface Modification of Lipid-Based Nanoparticles. | ACS Nano | 2022 | https://conductscience.org/library/papers/35446546 | PubMed |
| 10 | 32127636 | pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. | Commun Biol | 2020 | https://conductscience.org/library/papers/32127636 | PubMed |
| 11 | 39015802 | Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39015802 | PubMed |
| 12 | 30368954 | Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I. | Adv Mater | 2018 | https://conductscience.org/library/papers/30368954 | PubMed |
| 13 | 34699691 | The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non-small cell lung cancer patients with epidermal growth factor receptor mutation. | Cancer Commun (Lond) | 2021 | https://conductscience.org/library/papers/34699691 | PubMed |
| 14 | 31602823 | Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2020 | https://conductscience.org/library/papers/31602823 | PubMed |
| 15 | 30390118 | The micromechanics of lung alveoli: structure and function of surfactant and tissue components. | Histochem Cell Biol | 2018 | https://conductscience.org/library/papers/30390118 | PubMed |
| 16 | 32234467 | Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. | Int J Antimicrob Agents | 2020 | https://conductscience.org/library/papers/32234467 | PubMed |
| 17 | 27710833 | CaCO3 nanoparticles as an ultra-sensitive tumor-pH-responsive nanoplatform enabling real-time drug release monitoring and cancer combination therapy. | Biomaterials | 2016 | https://conductscience.org/library/papers/27710833 | PubMed |
| 18 | 39605063 | Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39605063 | PubMed |
| 19 | 33400957 | Self-assembled mRNA vaccines. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/33400957 | PubMed |
| 20 | 25260098 | Functional nanomaterials for phototherapies of cancer. | Chem Rev | 2014 | https://conductscience.org/library/papers/25260098 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42749398 | mRNA-based therapeutics in lung Cancer: Mechanisms, applications, and translational challenges. | J Genet Eng Biotechnol | 2026 | https://conductscience.org/library/papers/42749398 | PubMed |
| 42733877 | Hyaluronic Acid-Modified Celecoxib-Loaded Nanostructured Lipid Carriers Combined with Dissolving Microneedles for Targeted Sustained-Release Therapy in Osteoarthritis. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42733877 | PubMed |
| 42493486 | Enhancing pulp regeneration through metabolic reprogramming of mature dental pulp stem cells mediated by GLUT1/HK2 mRNA delivery. | Int J Oral Sci | 2026 | https://conductscience.org/library/papers/42493486 | PubMed |
| 41728072 | Exosome Augmentation Technologies for Drug Delivery and Disease Treatment: A Review. | Biomater Res | 2026 | https://conductscience.org/library/papers/41728072 | PubMed |
| 40709686 | Developing Biomaterial-Based mRNA Delivery System for Lung Disease Treatment. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40709686 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40709686
GET https://conductscience.org/api/papers/v1/40709686/references?page=2